Inhibition of GSK3 by lithium, from single molecules to signaling networks

L Freland, JM Beaulieu - Frontiers in molecular neuroscience, 2012‏ - frontiersin.org
For more than 60 years, the mood stabilizer lithium has been used alone or in combination
for the treatment of bipolar disorder, schizophrenia, depression, and other mental illnesses …

Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights

M Zamanpoor - Psychiatric genetics, 2020‏ - journals.lww.com
Schizophrenia is a common multigenic and debilitating neurological disorder characterized
by chronic psychotic symptoms and psychosocial impairment. Complex interactions of …

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users

M Di Forti, C Iyegbe, H Sallis, A Kolliakou… - Biological …, 2012‏ - Elsevier
BACKGROUND: Cannabis use is associated with an increased risk of psychosis. One study
has suggested that genetic variation in the AKT1 gene might influence this effect …

The DRD2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in …

L Shi, H Chen, K Chen, C Zhong, C Song… - Clinical Cancer …, 2023‏ - aacrjournals.org
Purpose: Temozolomide resistance remains a major obstacle in the treatment of
glioblastoma (GBM). The combination of temozolomide with another agent could offer an …

Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors

JM Beaulieu, T Del'Guidice, TD Sotnikova… - Frontiers in molecular …, 2011‏ - frontiersin.org
Brain dopamine receptors have been preferred targets for numerous pharmacological
compounds developed for the treatment of various neuropsychiatric disorders. Recent …

Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments

G Bartzokis - Neuropharmacology, 2012‏ - Elsevier
Current psychiatric diagnostic schema segregate symptom clusters into discrete entities,
however, large proportions of patients suffer from comorbid conditions that fit neither …

Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis

M Colizzi, C Iyegbe, J Powell, G Ursini… - Schizophrenia …, 2015‏ - academic.oup.com
Both cannabis use and the dopamine receptor (DRD2) gene have been associated with
schizophrenia, psychosis-like experiences, and cognition. However, there are no published …

Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies

J Kambeitz, A Abi-Dargham, S Kapur… - The British Journal of …, 2014‏ - cambridge.org
BackgroundThe hypothesis that cortical dopaminergic alterations underlie aspects of
schizophrenia has been highly influential. AimsTo bring together and evaluate the imaging …

Antipsychotic drug responsiveness and dopamine receptor signaling; old players and new prospects

A Rampino, A Marakhovskaia, T Soares-Silva… - Frontiers in …, 2019‏ - frontiersin.org
Antipsychotic drugs targeting dopamine neurotransmission are still the principal mean of
therapeutic intervention for schizophrenia. However, about one third of people do not …

Treatment-resistant schizophrenia: genetic and neuroimaging correlates

A Vita, A Minelli, S Barlati, G Deste… - Frontiers in …, 2019‏ - frontiersin.org
Schizophrenia is a severe neuropsychiatric disorder that affects approximately 0.5–1% of
the population. Response to antipsychotic therapy is highly variable, and it is not currently …